Literature DB >> 26590344

RAN Translation in Huntington Disease.

Monica Bañez-Coronel1, Fatma Ayhan1, Alex D Tarabochia1, Tao Zu1, Barbara A Perez1, Solaleh Khoramian Tusi2, Olga Pletnikova3, David R Borchelt4, Christopher A Ross5, Russell L Margolis6, Anthony T Yachnis7, Juan C Troncoso8, Laura P W Ranum9.   

Abstract

Huntington disease (HD) is caused by a CAGCTG expansion in the huntingtin (HTT) gene. While most research has focused on the HTT polyGln-expansion protein, we demonstrate that four additional, novel, homopolymeric expansion proteins (polyAla, polySer, polyLeu, and polyCys) accumulate in HD human brains. These sense and antisense repeat-associated non-ATG (RAN) translation proteins accumulate most abundantly in brain regions with neuronal loss, microglial activation and apoptosis, including caudate/putamen, white matter, and, in juvenile-onset cases, also the cerebellum. RAN protein accumulation and aggregation are length dependent, and individual RAN proteins are toxic to neural cells independent of RNA effects. These data suggest RAN proteins contribute to HD and that therapeutic strategies targeting both sense and antisense genes may be required for efficacy in HD patients. This is the first demonstration that RAN proteins are expressed across an expansion located in an open reading frame and suggests RAN translation may also contribute to other polyglutamine diseases.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26590344      PMCID: PMC4684947          DOI: 10.1016/j.neuron.2015.10.038

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  38 in total

Review 1.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.

Authors:  H Diana Rosas; David S Tuch; Nathanael D Hevelone; Alexandra K Zaleta; Mark Vangel; Steven M Hersch; David H Salat
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

3.  Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease.

Authors:  M A Nance; V Mathias-Hagen; G Breningstall; M J Wick; R C McGlennen
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

4.  Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts.

Authors:  André Toulouse; Faith Au-Yeung; Claudia Gaspar; Julie Roussel; Patrick Dion; Guy A Rouleau
Journal:  Hum Mol Genet       Date:  2005-08-08       Impact factor: 6.150

5.  The gait abnormality of Huntington's disease.

Authors:  W C Koller; J Trimble
Journal:  Neurology       Date:  1985-10       Impact factor: 9.910

6.  Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study.

Authors:  Sarah A J Reading; Michael A Yassa; Arnold Bakker; Adam C Dziorny; Lisa M Gourley; Venu Yallapragada; Adam Rosenblatt; Russell L Margolis; Elizabeth H Aylward; Jason Brandt; Susumu Mori; Peter van Zijl; Susan S Bassett; Christopher A Ross
Journal:  Psychiatry Res       Date:  2005-09-30       Impact factor: 3.222

7.  Early onset Huntington disease: a neuronal degeneration syndrome.

Authors:  Sara Seneca; Domique Fagnart; Kathelijn Keymolen; Willy Lissens; Daniele Hasaerts; Sara Debulpaep; Brigitte Desprechins; Inge Liebaers; Linda De Meirleir
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

8.  In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease.

Authors:  C Fennema-Notestine; S L Archibald; M W Jacobson; J Corey-Bloom; J S Paulsen; G M Peavy; A C Gamst; J M Hamilton; D P Salmon; T L Jernigan
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

9.  Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.

Authors:  G Schilling; M W Becher; A H Sharp; H A Jinnah; K Duan; J A Kotzuk; H H Slunt; T Ratovitski; J K Cooper; N A Jenkins; N G Copeland; D L Price; C A Ross; D R Borchelt
Journal:  Hum Mol Genet       Date:  1999-03       Impact factor: 6.150

10.  Microglial activation correlates with severity in Huntington disease: a clinical and PET study.

Authors:  N Pavese; A Gerhard; Y F Tai; A K Ho; F Turkheimer; R A Barker; D J Brooks; P Piccini
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

View more
  142 in total

Review 1.  Small molecule targeting of RNA structures in neurological disorders.

Authors:  Alicia J Angelbello; Jonathan L Chen; Matthew D Disney
Journal:  Ann N Y Acad Sci       Date:  2019-04-09       Impact factor: 5.691

2.  Huntington's disease brain-derived small RNAs recapitulate associated neuropathology in mice.

Authors:  Jordi Creus-Muncunill; Anna Guisado-Corcoll; Veronica Venturi; Lorena Pantano; Georgia Escaramís; Marta García de Herreros; Maria Solaguren-Beascoa; Ana Gámez-Valero; Cristina Navarrete; Mercè Masana; Franc Llorens; Daniela Diaz-Lucena; Esther Pérez-Navarro; Eulàlia Martí
Journal:  Acta Neuropathol       Date:  2021-02-06       Impact factor: 17.088

Review 3.  New pathologic mechanisms in nucleotide repeat expansion disorders.

Authors:  C M Rodriguez; P K Todd
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

4.  Repeat-associated non-ATG (RAN) translation.

Authors:  John Douglas Cleary; Amrutha Pattamatta; Laura P W Ranum
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

Review 5.  Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.

Authors:  Teresa Botta-Orfila; Gian Gaetano Tartaglia; Aubin Michalon
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

6.  Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9.

Authors:  Ranjan Batra; David A Nelles; Elaine Pirie; Steven M Blue; Ryan J Marina; Harrison Wang; Isaac A Chaim; James D Thomas; Nigel Zhang; Vu Nguyen; Stefan Aigner; Sebastian Markmiller; Guangbin Xia; Kevin D Corbett; Maurice S Swanson; Gene W Yeo
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 7.  AAV: An Overview of Unanswered Questions.

Authors:  Kenneth I Berns; Nicholas Muzyczka
Journal:  Hum Gene Ther       Date:  2017-04       Impact factor: 5.695

Review 8.  Models and mechanisms of repeat expansion disorders: a worm's eye view.

Authors:  Paige Rudich; Todd Lamitina
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 9.  A role for autophagy in Huntington's disease.

Authors:  Katherine R Croce; Ai Yamamoto
Journal:  Neurobiol Dis       Date:  2018-08-24       Impact factor: 5.996

Review 10.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.